---
id: mallory-weiss-tear
condition: Mallory-Weiss Tear
aliases: [Mallory-Weiss syndrome, gastroesophageal junction tear, MWT]
icd10: [K22.6]
esi: 3
time_to_harm: "< 12-24 hours (most self-limited; severe hemorrhage risk in coagulopathic or portal hypertensive patients)"
category: gastrointestinal
track: tier1
sources:
  - type: review
    ref: "Endoscopic Management of Mallory-Weiss Tearing, Clin Endosc 2015;48(2):102-105"
  - type: review
    ref: "Mallory-Weiss Syndrome, StatPearls Publishing 2024"
  - type: guideline
    ref: "ACG Clinical Guideline: Management of Patients with Acute Lower Gastrointestinal Bleeding, Am J Gastroenterol 2023;118(2):208-231"
last_updated: "2026-03-01"
compiled_by: agent
risk_tier: C
validation:
  automated_consistency_check: null
  dose_range_validator: null
  unit_normalization_check: null
  cross_file_consistency_check: null
  citation_presence_check: null
  duplicate_content_check: null
  outlier_detection_flag: clear
  schema_version: "2.0"
  provenance_links: []
---
# Mallory-Weiss Tear

## Recognition

**Presentation:**
- Hematemesis (bright red blood or coffee-ground emesis) following forceful or prolonged vomiting, retching, or straining
- Classic history: episode(s) of vomiting → hematemesis
- Blood may also appear as melena if bleeding is moderate-slow
- Epigastric or substernal pain
- ~90% of Mallory-Weiss tears stop bleeding spontaneously

**Common precipitants:**
- Forceful/prolonged vomiting (alcohol binge, cyclic vomiting, bulimia)
- Violent retching, coughing, hiccups, straining
- Endoscopy, CPR (iatrogenic)

**Risk factors for significant bleeding:**
- Portal hypertension / cirrhosis (varices alter GEJ anatomy)
- Coagulopathy (anticoagulant use, liver disease)
- Thrombocytopenia
- NSAID or aspirin use

**Exam findings:**
- Hematemesis on history or witnessed
- May be hemodynamically normal (majority) or tachycardic/hypotensive (significant bleed)
- Epigastric tenderness (mild)
- Stigmata of liver disease in cirrhotic patients

## Critical Actions

1. **Assess hemodynamic stability** — IV access (2 large-bore), isotonic crystalloid resuscitation
2. **CBC, BMP, coagulation studies, type and crossmatch** if significant bleeding
3. **IV PPI:** pantoprazole 80 mg IV bolus, then 8 mg/hr infusion (reduces rebleeding)
4. **Antiemetics:** ondansetron 4 mg IV to stop ongoing vomiting/retching
5. **GI consultation for endoscopy** within 24 hours if ongoing bleeding or hemodynamic instability
6. **Transfuse PRBCs** if Hgb < 7 g/dL or hemodynamically unstable despite fluids
7. **Correct coagulopathy** if INR > 2 and actively bleeding: vitamin K 10 mg IV, FFP, or 4-factor PCC
8. **Hold anticoagulants and antiplatelets** temporarily

## Differential Diagnosis

- **Boerhaave syndrome (transmural esophageal perforation)** — severe retrosternal pain, subcutaneous emphysema, pneumomediastinum; much more serious
- **Esophageal varices** — massive hematemesis, known cirrhosis/portal hypertension; requires variceal band ligation
- **Peptic ulcer disease (bleeding)** — epigastric pain, NSAID/H. pylori history; visible vessel or adherent clot on EGD
- **Esophagitis** — dysphagia, odynophagia, GERD history; diffuse mucosal changes on EGD
- **Dieulafoy lesion** — massive GI bleed from submucosal artery; no preceding vomiting
- **Gastric malignancy** — weight loss, anemia, ulcerated mass on EGD

## Workup

- **Labs:** CBC (Hgb baseline and serial), BMP, coagulation studies (PT/INR), type and crossmatch (if significant bleeding), hepatic panel if liver disease suspected
- **Upper endoscopy (EGD):**
  - Diagnostic and therapeutic gold standard
  - Reveals longitudinal mucosal tear at gastroesophageal junction (usually on gastric side along lesser curvature)
  - Timing: within 24 hours; emergent if hemodynamically unstable
  - Active bleeding seen in ~10% at time of endoscopy
- **CT angiography:** if endoscopy unavailable or fails and active hemorrhage suspected
- **Abdominal X-ray/CT:** if perforation (Boerhaave) is on differential — look for pneumomediastinum, pleural effusion

## Treatment

**Conservative (majority of cases — 90% self-limited):**
- IV PPI: pantoprazole 80 mg IV bolus then 8 mg/hr continuous infusion x 72 hours
- Antiemetics: ondansetron 4 mg IV q6h PRN
- NPO until bleeding controlled, then clear liquids → advance diet
- IV fluids, monitor Hgb q6-12h

**Endoscopic hemostasis (for active bleeding or high-risk stigmata):**
- Band ligation (preferred — lowest rebleeding rate)
- Hemoclip placement
- Epinephrine injection (1:10,000 dilution, 1-2 mL aliquots) — adjunctive only, not monotherapy
- Argon plasma coagulation
- Thermal coagulation (bipolar/heater probe)

**Refractory bleeding:**
- Angiographic embolization (interventional radiology) — for failed endoscopic hemostasis
- Balloon tamponade (Sengstaken-Blakemore) — temporizing in massive hemorrhage with portal hypertension
- Surgery (oversewing of tear via gastrotomy) — rare, last resort

**Blood product support:**
- Transfuse PRBCs for Hgb < 7 g/dL (< 8 g/dL in active coronary disease)
- FFP or 4-factor PCC for INR > 2 with active bleeding
- Platelets if < 50,000 with active bleeding

## Disposition

- **Discharge (majority):** hemodynamically stable, no active bleeding, Hgb stable on serial checks, tolerating PO, reliable follow-up
  - Prescribe PPI: pantoprazole 40 mg PO daily x 4-8 weeks
  - Antiemetic: ondansetron 4 mg PO q8h PRN
  - Avoid alcohol, NSAIDs
  - Return precautions: recurrent hematemesis, melena, lightheadedness, syncope
- **Admit:** hemodynamic instability, significant drop in Hgb (> 2 g/dL), active bleeding requiring endoscopic intervention, coagulopathy, high-risk features (portal hypertension, ongoing anticoagulation)
- **ICU:** massive hemorrhage, hemodynamic instability requiring vasopressors or massive transfusion

## Pitfalls

1. **Assuming all post-emesis hematemesis is Mallory-Weiss.** Boerhaave syndrome (transmural perforation) presents similarly but is life-threatening. Retrosternal chest pain, subcutaneous emphysema, or dyspnea mandate chest imaging to exclude perforation.

2. **Missing variceal bleeding in a cirrhotic patient.** Portal hypertensive patients can have concurrent Mallory-Weiss and variceal bleeding. Low threshold for EGD; manage as variceal bleed until proven otherwise (octreotide, antibiotics, band ligation).

3. **Discharging a patient too early without serial hemoglobin checks.** Initial Hgb may be falsely normal due to hemoconcentration. Repeat at 4-6 hours after fluid resuscitation.

4. **Using epinephrine injection alone as endoscopic therapy.** Injection monotherapy has unacceptable rebleeding rates. Combine with mechanical hemostasis (clips or banding).

5. **Failing to address the underlying cause of vomiting.** Treating the tear without managing the precipitant (alcohol use disorder, bulimia, cyclic vomiting syndrome) leads to recurrence.
